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Evaluation of Coronary 
Artery–Saphenous Vein 
Composite Grafts:
The Aortic No-Touch Technique
We retrospectively compared the results of conventional coronary artery bypass grafting 
(CABG) performed on patients who showed no preoperative evidence of serious athero-
sclerosis of the ascending aorta with the results of the aortic no-touch technique (using 
coronary artery–saphenous vein composite grafts) on CABG patients who did show such 
evidence.
From 2003 through 2012, 3,152 consecutive patients underwent isolated primary 
CABG at our hospital. We chose 360 for the current study. The study group (n=120) com-
prised patients who had undergone operation via the aortic no-touch technique. Propen-
sity-score-matching (1:2) was used to select the control group of 240 patients who had 
undergone conventional CABG. Early and late survival rates, reintervention-free survival 
rates, and freedom from cardiac death were compared.
Early and late mortality rates were similar in the study and control groups (P=0.19 vs 
P=0.29, respectively), as were cardiac-related death (2.5% vs 2.1%, respectively; P=0.53) 
and overall death (8.3% vs 7.9%, respectively; P=0.51). Overall survival rates were 91.7% 
vs 92.1% and freedom-from-cardiac-death rates were 97.4% vs 97.5% (P=0.71 vs P=0.78, 
respectively; mean follow-up period, 5.27 ± 2.51 yr). Reintervention-free survival rates 
were also similar (96.7% vs 98.8%, respectively; P=0.2).
As a result of the similar rates of early and late survival, reintervention-free survival, and 
freedom from cardiac death, we conclude that the aortic no-touch technique with com-
posite grafts might be a reasonable option in patients who have atherosclerotic ascending 
aorta that cannot be clamped. (Tex Heart Inst J 2014;41(1):26-32)
P orcelain aorta or disseminated atherosclerotic involvement of the entire ascend-ing aorta presents major surgical limitations during coronary artery bypass grafting (CABG). Chief among these is the need to avoid aortic cross-clamp-
ing, in order to circumvent neurologic and other sequelae.1 One alternative to cross-
clamping is to bypass the aorta with a composite of one or more saphenous vein (SV) 
and radial artery grafts anastomosed to the left internal mammary artery (LIMA), 
which previously has been anastomosed to the left anterior descending coronary artery. 
These grafts are also known as Y or T composite grafts.
 Although the safety and efficacy of arterial composite grafts for total arterial revas-
cularization have been proved,2,3 the safety and efficacy of venous composite grafts are 
still widely debated. Hwang and colleagues4 have reported that the SV composite graft 
can be used as an alternative to the arterial composite graft. However, Gaudino and 
associates5 have maintained that the patency of SV composite grafts is suboptimal.
 The objectives of our study were to compare SV-composite-graft results with con-
ventional coronary-artery-graft results in particular regard to reintervention-free sur-
vival, freedom from cardiac death, and early and late mortality rates.
Patients and Methods
Retrospectively, we collected the data of 3,152 consecutive patients who had under-
gone either conventional CABG or “aortic no-touch” CABG (with the aid of coronary 
artery–SV composite grafting) from January 2003 through January 2012. Of those 
3,152 patients at our institution, 360 were included in this current study. Patients with 
ascending aortic disease (porcelain aorta or disseminated atherosclerotic involvement 
of the entire ascending aorta) had undergone “aortic no-touch” CABG with use of an 
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SV composite graft; these patients (n=120) comprised 
the study group (Table I). The control group (n=240) 
was drawn (using 1:2 propensity-score-matching; see 
Tables II and III) from the 3,032 patients who had un-
dergone standard CABG.
Preoperative Evaluation
All patients scheduled for CABG underwent preopera-
tive evaluation of atherosclerosis of the ascending aorta, 
the aortic arch, and the descending aorta. In patients 
older than 70 years, this screening was performed via 
multidetector computed tomography (CT). In those 
younger than 70 years, CT was performed only if there 
was carotid bruit; a history of stroke or transient isch-
emic attack (TIA); the presence of diabetes mellitus, 
peripheral vascular disease, or left main coronary artery 
disease; or the detection of calcif ication in the aortic 
arch on chest radiography.
 For this study, all CT scans were obtained using a 
Siemens Somatom® Sensation 4 CT scanner (Siemens 
Medical Solutions; Forchheim, Germany). The scan 
settings were 3-mm slice thickness, 2.5-mm collima-
tion, and 5-mm table increment. The area scanned 
extended from the thoracic inlet to the level of the 
aortic root, 3 cm distal from the origin of the coronary 
artery.
TABLE I. Preoperative and Postoperative Baseline Characteristics of the Study Cohort and the Entire Patient Population
 Study Group Entire Population  
               Variable (n=120) (n=3,032) P Value
Demographic
    Women 20 (16.7) 864 (28.5) 0.004
    Age (yr) 67 (44–83) 60 (22–89) <0.001
Extent of Coronary Artery Disease    0.002
   Single-vessel 8 (6.7) 259 (8.5) —
   2-vessel 50 (41.7) 625 (20.6) —
   Multivessel 62 (51.7) 2,147 (70.8) —
Left main stem 5 (4.2) 139 (4.6) 0.52
LVEF    0.15
   ≤0.30 16 (13.4) 307 (10.1) —
   >0.30 103 (86.6) 2,752 (89.9) —
Comorbidities   
   Atrial fibrillation 0 46 (1.5) 0.16
   Diabetes mellitus 41 (34.2) 1,189 (39.2) 0.15
   Renal insufficiency 11 (9.2) 163 (5.4) 0.01
   Peripheral vascular disease 18 (15) 167 (5.5) <0.001
   COPD 19 (15.8) 212 (7) 0.001
   Hypertension 76 (63.3) 1,460 (48.2) 0.002
   Dyslipidemia 64 (53.3) 1,128 (37.2) 0.001
   History of stroke or TIA 10 (8.3) 116 (3.8) 0.008
   Angina class III/IV 60 (50) 1,300 (43) 0.07
   Myocardial infarction 45 (37.5) 1,156 (38) 0.34
   Congestive heart failure 8 (6.7) 156 (5.1) 0.28
EuroScore 4 (0–11) 3 (0–14) <0.001
LV aneurysm repair 6 (5) 158 (5.2) 0.41
No. distal anastomoses 3.1 ± 0.9 3.3 ± 1.2 0.005
Postoperative stroke or TIA 3 (2.5) 18 (0.6) 0.17
Postoperative atrial fibrillation 24 (20) 254 (8.4) 0.01
IABP support 0 21 (0.7) 0.44
Inotropic support 18 (15) 638 (21) 0.06
ICU length of stay (d) 2.4 ± 3 2.2 ± 1.7 0.14
Hospital length of stay (d) 5.8 ± 4 5.3 ± 2.6 0.04
In-hospital death 0 52 (1.7) 0.39
 
COPD = chronic obstructive pulmonary disease; EuroScore = European System for Cardiac Operative Risk Evaluation; IABP = intra-
aortic balloon pump; ICU = intensive care unit; LVEF = left ventricular ejection fraction; TIA = transient ischemic attack 
 
Data are presented as mean ± SD, median and interquartile range, or number and percentage. P <0.05 was considered statistically  
significant.
Volume 41, Number 1, 201428      Saphenous Vein Composite Grafts
 Disease of the ascending aorta was determined to be 
untouchable if the vessel exhibited extensive intimal 
thickening, atheroma >3 mm in diameter, protruding 
atheroma, ulcerated atheroma, or one or more calcifica-
tions of any size.
 Carotid artery Doppler ultrasonography was per-
formed in all patients older than 60 years of age; in 
patients with carotid bruit; in those with a history 
of stroke or TIA; in those with diabetes mellitus, pe-
ripheral vascular disease, or left main coronary artery 
disease; and in those with aortic calcification on chest 
radiography.
Surgical Technique
Median sternotomy was performed in all 360 patients. 
The LIMA and SV were harvested by means of stan-
dard techniques. The decision in regard to whether a 
patient would undergo the procedure on-pump or off-
pump was made by the same surgeons (RT and OG), 
in consideration of the absence or presence of ascending 
aortic disease.
 The patients with ascending aortic disease (unclamp-
able ascending aorta) underwent surgery with the no-
touch technique.1,2,4,5 Off-pump coronary surgery was 
preferred whenever possible (70/120). On-pump pro-
cedures were used in patients whose circumflex systems 
were considered unable to tolerate off-pump myocardial 
revascularization (50/120).
 In each of the 3,152 subjects, the ascending aorta was 
routinely evaluated by intraoperative aortic palpation 
(the method described by Mills and Everson6). The site 
of aortic cannulation in the study-group patients was 
determined after the patients’ CT scans were studied 
preoperatively. Patients with Mills and Everson mod-
erate-grade atherosclerosis were cannulated through 
the soft site in the aorta identif ied upon palpation 
(n=35/50).6 Patients with Mills and Everson severe-
grade atherosclerosis underwent femoral artery cannula-
tion (n=15/50).6
 An Optima XP® membrane oxygenator (Cobe Car-
diovascular, Inc., a subsidiary of Sorin S.p.A.; Arvada, 
Colo) was used in conventional CABG. Tepid hypo-
TABLE II. Baseline Characteristics of the Study and Control Groups after Propensity-Score-Matching
 Study Group Control Group  
            Variable (n=120) (n=240) P Value
Demographic   
   Women 20 (16.7) 57 (23.8) 0.07
   Age (yr) 67 (44–83) 68 (42–85) 0.46
Extent of Coronary Artery Disease    0.19
   Single-vessel 8 (6.7) 17 (7.1) 
   2-vessel 50 (41.7) 77 (32.1) 
   Multivessel 62 (51.7) 146 (60.8) 
Left main stem 5 (4.2) 4 (1.7) 0.14
LVEF   0.41
   ≤0.30 16 (13.4) 29 (12.1) 
   >0.30 103 (86.6) 211 (87.9) 
Comorbidities   
   Atrial fibrillation 0  6 (1.7) 0.08
   Diabetes mellitus 41 (34.2) 99 (41.3) 0.11
   Renal insufficiency 11 (9.2) 22 (9.2) 0.58
   Peripheral vascular disease 18 (15) 22 (9) 0.07
   COPD 19 (15.8) 32 (13.3) 0.31
   Hypertension  76 (63.3) 158 (65.8) 0.36
   Dyslipidemia 64 (53.3) 102 (42.5) 0.05
   Unstable angina pectoris 12 (10) 26 (10.8) 0.48
   History of stroke or TIA 10 (8.3) 19 (7.9) 0.51
   Angina class III/IV 60 (50) 106 (44.2) 0.17
   Myocardial infarction 45 (37.5) 91 (37.9) 0.51
   Congestive heart failure 8 (6.7) 13 (5.4) 0.39
EuroScore 4 (0–11) 4 (0–13) 0.26
Operative Priority    0.22
   Elective 103 (85.8) 214 (89.2) 
   Urgent or emergent 17 (14.2) 26 (10.8) 
 
COPD = chronic obstructive pulmonary disease; EuroScore = European System for Cardiac Operative Risk Evaluation; LVEF = left  
ventricular ejection fraction; TIA = transient ischemic attack 
 
Data are presented as mean ± SD, median and interquartile range, or number and percentage. P <0.05 was considered statistically  
significant.
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thermia (33 °C) was maintained during cardiopulmo-
nary bypass.
 In the study group, an Octopus® 2 tissue stabilizer 
(Medtronic, Inc.; Minneapolis, Minn) or an epicardial 
retracting stabilizer (Chase Medical; Richardson, Tex) 
was used to stabilize the target coronary vessel. The tar-
get vessel was occluded proximally by using a double 
loop with a Surg-I-Loop® Plus Occlusive Loop (Scanlan 
International, Inc.; St. Paul, Minn) or an 8-mm bulldog 
clamp. The distal portion of the vessel was occluded 
when excessive backflow began to obstruct the surgeon’s 
view. A carbon dioxide blower was used routinely.
 In the present study, SV composite grafting with the 
in situ LIMA was the preferred method of revascu-
larization. For proximal anastomosis, the target vessel 
was anastomosed to the LIMA. The inf low was the 
LIMA in all patients. In patients who required distal 
anastomosis of the circumflex system, both venae cavae 
were released from the pericardium and the pleura was 
opened on the right side, enabling the heart to rotate to 
the right. Deep pericardial traction sutures were used to 
elevate and rotate the heart. A suction-based Starfish® 
Heart Positioner (Medtronic) maintained hemodynam-
ic stability during lateral-wall anastomosis.
Evaluation of Long-Term Clinical Outcomes
Patients underwent regular postoperative follow-up 
monitoring through the outpatient clinic at 3-, 6-, and 
12-month intervals, and were contacted by telephone 
in the event that the last clinic visit was not conducted 
at the scheduled time. Follow-up monitoring was com-
pleted for all surviving patients on 1 September 2012. 
Cardiac death was defined as any death that arose from 
cardiac events during the follow-up period.
Statistical Analysis
Statistical analysis was performed with the use of SPSS 
software version 17.0 (IBM Corporation; Armonk, 
NY). All numerical data were expressed as mean ± SD, 
median and interquartile range, or proportions. The 
TABLE III. Surgical Outcomes after Propensity-Score Matching
 Study Group Control Group  
             Variable (n=120) (n=240) P Value
Operative Data
  Left ventricular aneurysm repair 6 (5) 8 (3.3) 0.3
  Carotid endarterectomy 2 (1.7) 4 (1.7) 0.68
Bypass Grafts
  No. distal anastomoses 3.1 ± 0.9 3.3 ± 1.1 0.08
  Saphenous vein graft 116 (96.7) 221 (92.1) 0.07
Coronary Artery
  LAD 120 (100) 240 (100) —
  Diagonal branch 58 (48.3) 135 (56.3) 0.09
  Obtuse marginal branch 91 (71.7) 185 (77.1) 0.44
  Right coronary artery 83 (69.2) 156 (65) 0.25
  Intermediate 21 (17.5) 33 (13.8) 0.21
  Sequential anastomosis 20 (16.7) 49 (20.4) 0.24
Postoperative Complication
  Inotropic support 18 (15) 60 (25) 0.01
  IABP support 0 1 (0.4) 0.66
  Stroke or TIA 3 (2.5) 6 (2.5) 0.65
  Atrial fibrillation 24 (20) 42 (17.5) 0.32
  Gastrointestinal complication 1 (0.8) 3 (1.3) 0.59
  Pulmonary complication 6 (5) 12 (5) 0.61
  Renal insufficiency 17 (14) 28 (11.7) 0.3
  Re-exploration for bleeding 1 (0.8) 2 (0.8) 0.74
  Mediastinitis 0 2 (0.8) 0.44
  Wound  1 (0.8) 6 (2.5) 0.26
  ICU length of stay (d) 2.4 ± 3 2.2 ± 1 0.28
  Hospital length of stay (d) 5.8 ± 4 5.5 ± 2 0.1
Death
  From cardiac causes 3 (2.5) 5 (2.1) 0.53
  In-hospital 0  4 (1.7) 0.19
  Late 10 (8.3) 15 (6.3) 0.29
  All-cause 10 (8.3) 19 (7.9) 0.51
 
IABP = intra-aortic balloon pump; ICU = intensive care unit; LAD = left anterior descending coronary artery; TIA = transient ischemic 
attack 
 
Data are presented as mean ± SD or as number and percentage. P <0.05 was considered statistically significant.
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Kolmogorov-Smirnov test was used to evaluate the nor-
mality of data. Continuous variables were compared by 
the use of Student’s t test or the Mann-Whitney U test, 
depending on parametric and nonparametric distribu-
tion, respectively. The categorical variables between the 
groups were analyzed by using the c2 test or the Fisher 
exact test. In order to determine which patients were 
to be included in our control group, we performed a 
1:2 matching of study group–control group patients in 
regard to age, sex, coronary artery disease, myocardial 
infarction, left ventricular dysfunction (expressed by 
ejection fraction), congestive heart failure (CHF), dia-
betes mellitus, smoking, renal insufficiency, peripheral 
vascular disease, hypertension, chronic obstructive pul-
monary disease (COPD), dyslipidemia, and emergency 
operation. Propensity-score-matching analysis was per-
formed to correct the effects of nonrandomization in 
this retrospective study and of selection bias. Propensity 
scores were calculated with the aid of Stata® version 10 
software (StataCorp LP; College Station, Texas). Sur-
vival rates were estimated by the Kaplan-Meier method, 
and comparisons between the 2 groups were performed 
with use of the log-rank test. The level for statistical 
significance was predetermined at P <0.05.
Results
Table I shows the baseline clinical characteristics of the 
study cohort and the entire patient population. The pa-
tients in the study group were older than the patient 
group as a whole (P <0.001), they had more peripheral 
vascular disease (P <0.001), and they had higher Euro-
Score values (P <0.001). The study group had statisti-
cally significantly higher rates of COPD, dyslipidemia, 
and history of stroke or TIA.
 Table II shows the baseline clinical characteristics of 
the study and control groups after propensity-score-
matching. The mean age of the study group was 67 ± 
7 years, and 20% were women. Most patients in both 
groups had multivessel disease (P=0.19). Mean left ven-
tricular ejection fractions were similar (0.46 ± 0.09 vs 
0.48 ± 0.11; P=0.08) between the study group and the 
entire patient population.
 Patients with composite grafts had similar preopera-
tive comorbidities when compared with control sub-
jects. Of no statistical signif icance were differences 
between the 2 groups in EuroScore or in their histories 
of diabetes, peripheral vascular disease, dyslipidemia, 
renal insufficiency, COPD, CHF, angina class III/IV, 
stroke or TIA, or unstable angina pectoris.
 In 30% of patients (n=36), LIMA–SV graft Y anas-
tomoses were performed. As necessary, K anastomoses 
were done in 13 patients (10.8%), T in 41 (34.1%), and 
K and I in 30 (25%) (Figs. 1 and 2). The percentages of 
sequential anastomoses were similar (16.7% vs 20.4%, 
respectively; P=0.24) in the study and control groups.
 Table III shows the surgical outcomes of the study 
and control groups after propensity-score-matching. 
Postoperative inotropic support, atrial fibrillation, pul-
monary complications, and renal insuff iciency were 
similar in the 2 groups.
 Postoperative stroke and TIA were similar in the 2 
groups (P=0.65). In the study group, 3 patients (2.5%) 
experienced neurologic complications. In the control 
Fig. 2  Coronary angiogram performed at 9-year follow-up in a 
72-year-old male patient shows a left internal mammary artery–
saphenous vein “T” composite graft: the left internal mammary 
artery was anastomosed to the left anterior descending coronary 
artery, and the saphenous vein grafts were anastomosed to the 
diagonal and obtuse marginal branches.
Fig. 1  Diagrams show the construction of composite grafts. 
 
Dx = diagonal branch; LAD = left anterior descending coronary 
artery; LIMA = left internal mammary artery; OM = obtuse  
marginal branch; RCA = right coronary artery
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group, 6 patients (2.5%) had neurologic complications. 
Only one patient had perioperative embolic stroke in 
the study group, whereas 4 patients experienced peri-
operative embolic stroke in the control group.
 The mean follow-up time was 5.27 ± 2.51 years for 
the study group and 5.28 ± 2.53 years for the control 
group (P=0.97). Overall follow-up was 5.27 ± 2.52 
years. During this period, there were 29 deaths: 10 
(8.3%) among study patients (cardiac-related deaths in 
3 patients, stroke in 3, cancer in 2, and sudden death 
in 2) and 19 among control patients (cardiac-related 
deaths in 5 patients, stroke in 4, cancer in 3, gastroin-
testinal bleeding in 1, and unknown in 6).
 Hospital mortality rates (0 vs 1.7%, respectively; 
P=0.19) and late mortality rates (8.3% vs 6.3%, re-
spectively; P=0.29) were similar. Cardiac-related deaths 
(2.5% vs 2.1%, respectively; P=0.53), and overall mor-
tality rates (8.3% vs 7.9%, respectively; P=0.51) were 
similar between groups (Table III).
 In 2 individuals in the study group, revasculariza-
tion was incomplete because of technical difficulties in 
attaining access to the right coronary artery (posterior 
descending branch) system. In these cases, hybrid treat-
ment (with percutaneous transluminal coronary angio-
plasty) was used to deal with the right coronary lesion.
 The overall survival rates at a mean follow-up time 
of 5.27 ± 2.52 years were 91.7% for the study group 
and 92.1% for the control group; freedom-from-car-
diac-death rates were 97.5% and 97.9%, respectively. 
No significant difference was found in freedom-from-
cardiac-death rates between the 2 groups (P=0.71 vs 
P=0.78, respectively) (Figs. 3 and 4). Freedom-from-
reintervention rates at a mean follow-up time of 5.27 
± 2.52 years were 96.7% and 98.8%, in the study and 
control groups, respectively (P=0.2) (Fig. 5).
Discussion
The incidence of porcelain or diffusely atherosclerotic 
aorta ranges between 4% to 29% of all cases referred 
for myocardial revascularization procedures.1,7 Because 
of its potential to radically modify the surgical ap-
proach, the preoperative recognition of diseased aorta 
is of major importance. Regrettably, no reliable diag-
nostic criteria have been established to date, and the 
discovery of diseased aorta remains an intraoperative 
surprise in the great majority of patients in whom no 
preoperative evaluation of ascending aortic calcif ica-
tion is performed.1
 Some previous studies have shown significantly lower 
patency rates of SV grafts, when compared with the pa-
tency rates of radial artery grafts.8,9 On the other hand, 
a prominent study5 reported the results of CABG in 
28 patients in whom the LIMA–SV Y-composite graft 
had been used as the composite graft: the vein-graft 
patency rate was 96% at 2.5 postoperative years. Simi-
Fig. 3  Graph shows the Kaplan-Meier overall survival curve.
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Fig. 4  Graph shows the comparison of freedom from cardiac 
death in the 2 groups.
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Fig. 5  Graph shows the reintervention-free-survival curve in the 
2 groups.
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larly, a study by Hwang and colleagues4 revealed that 
the patency rate of SV grafts at 1 year was 92.1%, which 
was similar to that of arterial composite grafts (91%). 
Patency rates of venous grafts in accordance with their 
target coronary artery territories were also similar to 
those of arterial composite grafts.
 Our present study revealed 2 main f indings. First, 
the early and long-term mortality rates of patients who 
experienced the no-touch technique with a composite 
graft anastomosed to the in situ LIMA were similar to 
those of patients who underwent conventional CABG. 
Second, there were no signif icant differences in early 
and long-term clinical outcomes, including freedom 
from cardiac death, reintervention-free survival, and 
overall survival rates between the groups when both 
techniques were used.
 In the present study, freedom from cardiac death 
(97.5%), freedom from reintervention (96.7%), and 
overall survival rates (91.7%) between composite graft 
with no-touch aorta technique and matched groups of 
conventional CABG were similar. Our clinical results 
are parallel with and corroborated by studies in the lit-
erature.4
 The present study showed that the hospital mortality 
and postoperative morbidity rates associated with SV 
composite grafts, as well as the late clinical outcomes, 
are comparable to those of conventional CABG per-
formed in patients with nonatherosclerotic aorta. In the 
past, the no-touch technique has been shown to reduce 
the risk of cerebrovascular accident and has been associ-
ated with low rates of morbidity, stroke, and mortality 
during hospital stay and at mid-term follow-up.10 Our 
study has also found low neurologic complication rates.
 A study comparing radial artery and SV composite 
grafts revealed early clinical outcomes similar to ours 
in hospital deaths and postoperative morbidity, as well 
as in 1-year follow-up CT angiographic patency rates 
between the 2 groups.4 Presumably, an SV graft anas-
tomosed to the LIMA might be exposed to less pressure 
trauma or shear stress than a graft anastomosed to the 
ascending aorta. Mean and diastolic graft pressures of 
an SV graft anastomosed to the LIMA have been shown 
to be lower than those of an SV graft anastomosed to 
the ascending aorta.3 Hypothetically, the quality of the 
SV graft is identical to that of the radial artery, because 
the radial artery is equally prone to the development of 
intimal hyperplasia or fibrous or calcified plaques.
 Minimal manipulation and tension (for example, one 
should avoid the use of a pressure syringe for dilation), 
together with the use of relatively short lengths of com-
posite vein graft, might improve the early and 1-year 
patency rates of SV grafts.4
Limitations of the Study
Our study has all the inherent weaknesses of retrospec-
tive studies. Also, the number of patients was relatively 
small and follow-up patency tests (CT and angiography) 
were not performed in all patients, so the sample size 
might not be sufficient to enable a definite conclusion.
Conclusion
We compared the results of conventional CABG as per-
formed on patients who showed no preoperative evi-
dence of serious atherosclerosis of the ascending aorta 
with the results of the aortic no-touch technique (using 
SV composite grafts) on CABG patients who did show 
such evidence. In comparing the conventional CABG 
and SV-composite-graft groups, our study showed simi-
lar early and late survival rates, similar reintervention-
free survival rates, and similar freedom from cardiac 
death. As a result, we conclude that the aortic no-touch 
technique with composite grafts might be a reasonable 
option in patients who have an atherosclerotic ascend-
ing aorta that cannot be clamped.
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